Navigation Links
Faithful mothers have healthier babies
Date:11/12/2009

Faculty of 1000 reviewers examine a study from New Zealand on whether prolonged exposure to the father's semen protects new mothers against pre-eclampsia and having an undersized baby

In this study by Kho and colleagues at the University of Auckland, published in the Journal of Reproductive Immunology, 2507 first-time pregnant women were interviewed about the length of their relationship with the baby's biological father.

When the pregnancies came to term, pre-eclampsia (pregnancy-induced hypertension) was found to be less common in women who had long-term sexual relations exclusively with the biological father, than in those who had been with their partner only for a short time (i.e. less than six months).

The study also revealed that women who had undersized babies (SGA, or 'small for gestational age') were also more likely to have been in shorter relationships, but only when 20 week ultrasounds demonstrated reduced blood flow to the fetus.

F1000 reviewer Dr Larry Chamley explains that "in normal pregnancies prolonged exposure of the female immune system to paternal antigens following intercourse (without barrier contraception) [could induce] tolerance of the maternal immune system to the paternal antigens.

But the exaggerated maternal inflammatory response in pre-eclampsia is due to a failure of the maternal immune system to down-regulate or tolerate its response to paternal antigens."

"Although the issue of whether prolonged semen exposure does protect against developing pre-eclampsia is not yet resolved," continued Dr Chamley, "this paper seems to tip the weight of evidence back in favour of suggesting that prolonged semen exposure is protective."


'/>"/>

Contact: Steve Pogonowski
press@f1000.com
Faculty of 1000: Biology and Medicine
Source:Eurekalert

Page: 1

Related biology news :

1. Safer, more accurate radiation therapy for expecting mothers
2. Hungry mothers risk addiction in their adult children
3. Negligent, attentive mouse mothers show biological differences
4. Too much or too little weight gain poses risks to pregnant mothers, babies
5. Mice mothers devote energies to offspring when life is threatened
6. Vitamin D deficiency in infants and nursing mothers carries long-term disease risks
7. Mothers pass on disease clues to offspring
8. Facebook flack regarding breastfeeding mothers
9. Older killer whales make the best mothers
10. Mothers of multiple births at increased odds of postpartum depression
11. Mothers give interlopers offspring a head start in life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 27, 2015   Zynx Health ... experience-based clinical improvement solutions, today announced that its ... now available on Android smartphones and tablets. With ... post-care organizations can use ZynxCarebook to securely exchange ... condition, streamline care transitions to other care settings, ...
(Date:7/21/2015)... YORK , July 21, 2015 ... systems, as seen in the recent U.S. Office ... a solution to the infosec conundrum, but developers ... is stored. To address this dilemma, Biometrics-as-a-Service provider ... its Biometric Tokenization SDK for third party integration. ...
(Date:7/9/2015)... , July 07, 2015 ... announced the addition of the "Biometrics for ... Forecasts 2015-2020" report to their offering. ... major contributor to this growth and the forecast ... billion in revenue for companies involved in delivering ...
Breaking Biology News(10 mins):Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... For the first time in nearly a century drinkers will ... heritage barley from the Victorian period. Old varieties ... the John Innes Centre revived Chevallier from the institute,s Genetic ... records indicate that the variety produced premium quality malt and ...
... analysis, carbon dioxide removal could be used under certain ... but it would not replace the bulk of actual ... allows to separate emissions control from the time and ... important for climate protection," says lead-author Elmar Kriegler. "You ...
... "Many of the great whales which once populated the oceans ... commercial hunting. The committee also worried about how tuna fishing ... And they considered reports about seal hunting and the decline ... October of that year, Congress passed the Marine Mammal Protection ...
Cached Biology News:Cheers to better beer and disease resistance 2CO2 removal can lower costs of climate protection 2CO2 removal can lower costs of climate protection 3Sea mammals find US safe harbor 2Sea mammals find US safe harbor 3Sea mammals find US safe harbor 4
(Date:7/30/2015)... , ... July 30, 2015 , ... ... of a field clinical study of its canine osteoarthritis stem cell product, currently ... Therapeutics (Kansas City, KS) and will be marketed in the US by Aratana. ...
(Date:7/30/2015)... Senomyx , Inc. (NASDAQ: SNMX ), a leading ... and commercialize novel flavor ingredients for the food, beverage, ... the second quarter 2015. "Moving into ... to achieve our commercial and financial goals," stated John ... "Since our last quarterly earnings report, our two partners ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/30/2015)... July 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... received the second $1.0M tranche under a previously ... grant valued at up to $3.0 million to ... surfactant as a potential medical countermeasure to mitigate ... was awarded an initial $1.0 million under this ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... Calif., Aug. 19 ReceptorBio,Inc. announced today that ... Inc. (Palo Alto, CA) (Nasdaq: TELK ) ... unique, oral small molecule insulin,receptor activators. These compounds ... drug discovery technology. The,agreement provides for payments related ...
... software,solutions provider for cheminformatics today announced the launch ... JChem. As well as,other improvements, the release sees ... 2 format useful for integrating with Microsoft Office,applications., ... of application programming,interfaces (API,s) and graphic user interfaces ...
... 19 Today Bavarian,Nordic published the company,s interim report ... available on the company,s website. Below is an,extract of ... as events,after the balance sheet date., In the ... DKK 23,million and recorded a loss before tax of ...
Cached Biology Technology:ReceptorBio Announces Diabetes License Agreement With Telik 2ReceptorBio Announces Diabetes License Agreement With Telik 3ChemAxon Launches Marvin and JChem Version 5.1; Name to Structure Generation, OLE 2 and JavaScript Integration 2Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 2Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 3Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 4Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 5Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 6Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 7Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 8Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 9Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008 10
Rabbit polyclonal to KIAA1276 ( Abpromise for all tested applications). entrezGeneID: 27146 SwissProtID: Q9ULE4...
Mouse monoclonal [LH8] to Cytokeratin 5 + 14 ( Abpromise for all tested applications). entrezGeneID: 3852 SwissProtID: P02533...
Rabbit polyclonal to IL23 P19 ( Abpromise for all tested applications). Antigen: Synthetic 16 amino acid peptide from near the amino terminus of human IL23 P19 Entrez Gene ID: 51561 Swiss...
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: